Literature DB >> 35039659

The value of patient-reported outcomes in early-phase clinical trials.

Ameeta Retzer1,2, Olalekan Lee Aiyegbusi1,2,3,4, Anna Rowe3,5, Philip N Newsome3,6, Jessica Douglas-Pugh5, Sheeba Khan3,6,7, Saloni Mittal8, Roger Wilson9, Daniel O'Connor10, Lisa Campbell10, Sandra A Mitchell11, Melanie Calvert12,13,14,15,16,17.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35039659     DOI： 10.1038/s41591-021-01648-4

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Patient-Reported Outcomes in Early Phase Clinical Trials: An Opportunity to Actively Promote Patient-Centered Care.

Authors:  Cristiane Decat Bergerot; Sumanta K Pal; Abhishek Tripathi
Journal:  Oncologist       Date:  2022-09-02       Impact factor: 5.837
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.